Establishment of a database of clinical data as well as a biobank for the investigation of SARS-CoV-2 (COVID-19) and other viral pneumonia: A clinic-wide study of the University Medical Center Greifswald

Establishment of a database of clinical data as well as a biobank for the investigation of SARS-CoV-2 (COVID-19) and other viral pneumonia: A clinic-wide study of the University Medical Center Greifswald - ViP-Trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023770

Enrollment

500

Registered

2021-03-22

Start date

2020-08-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.9

Interventions

Group 1: Patients with positive SARS-CoV-2 infection or other viral pneumonia will be taken blood samples at defined times. In addition, anamnestic data such as previous medical conditions and current

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: viral pneumonia

Exclusion criteria

Exclusion criteria: age under 18 years; refusal of participation

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the establishment of a biobank with medical data of patients with viral pneumonia.	—

Countries

Germany

Contacts

Public ContactKlaus Hahnenkamp

Universitätsmedizin Greifswald Körperschaft des öffentlichen Rechts Klinik für Anästhesiologie Anästhesie-, Intensiv-, Notfall- und Schmerzmedizin

klaus.hahnenkamp@med.uni-greifswald.de03834 86 5801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026